DOC vs JLL
Healthpeak Properties vs Jones Lang LaSalle — AI-powered side-by-side comparison
DOC
Healthpeak Properties
64
Buy
VS
JLL
Jones Lang LaSalle
66
Buy
| Metric | DOC | JLL |
|---|
| AI Score |
64
|
66
|
| Price |
$20.50
|
$363.17
|
| P/E Ratio |
58.60×
|
17.07×
|
| ROE |
1.0%
|
10.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
2.5%
|
89.6%
|
| Debt / Equity |
1.32×
|
0.34×
|
| Dividend Yield |
5.9%
|
0.0%
|
| RSI (14) |
31.1
|
56.0
|
| Beta |
0.991
|
1.24
|
| Expected Upside |
+1.6%
|
+0.5%
|
AI Committee View
Current Innellis committee reasoning for DOC versus JLL.
JLL leads by 2 points.
JLL scores 66/100 (Buy) versus DOC at 64/100 (Buy).
DOC Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Price trading below the lower Bollinger Band -- stretched to the downside — Technical
JLL Committee View
80% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 22.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Bollinger bandwidth of 22.0% signals elevated volatility — Risk